A shortage with a silver lining: A chance to reduce unneeded blood tests

Alert in doctors’ ordering system about scarce supplies leads to 29% drop in blood clotting tests; could provide model for other efforts to encourage wise use.

9:50 AM

Author | Kara Gavin

blood vials colorful lab notes
Getty Images

A pandemic-related shortage of a mundane item – tubes to collect blood samples from patients – has caused headaches for health systems worldwide.

But it may also have a silver lining: A lesson in how to reduce unneeded medical tests, whether or not there's a shortage, according to a new study.

The shortage of "blue top" blood test tubes gave researchers a chance to see if alerting doctors at the moment they're placing an order could encourage them to seek a test only when results will immediately affect care.

In the new study, published in JAMA Internal Medicine, an alert led to a nearly immediate 29% drop in orders for one common test. The reduced level persisted for months.

"This shows that small interventions can make a big difference, and suggests the potential for other types of low-value care to benefit from a similar intervention," said lead author Madison Breeden, M.D., a fellow in infectious diseases at U-M Health who conducted the study during her year as chief resident of Quality and Patient Safety. She's already exploring if the approach might reduce unnecessary prescribing of antibiotics.

Breeden and her colleagues describe what happened in spring 2021 when University of Michigan Health supply chain and pathology experts began worrying about a potential shortage of "blue top" tubes. The pandemic had created very high demand for the chemical the tubes contain: sodium citrate, which stabilizes blood samples until a laboratory team can analyze three blood clotting-related properties, called PT, INR and PTT.

After emailing all providers, U-M Health added a "best practices alert" to doctors' test-ordering electronic system. They could still order PT/INR/PTT tests, but were asked for "thoughtful restraint in reflexive ordering."

The alert began popping up a month before the United States Food and Drug Administration issued an official shortage notice and the issue got widespread attention. The shortage continues today and has grown to other types of tests.

The researchers looked at what happened for six months after the alert began appearing at U-M Health, and compared it with data from six months before.

"There are very important reasons to order this test in some patients, for instance before an operation or when managing certain conditions and treatments," Breeden explained. "But it may also be part of a standard order set that's put in during an emergency department visit and continues to be ordered repeatedly after the patient is admitted to the hospital, even though the results won't change their care."

For such patients, a one-time test might be indicated, but not repeated testing.

Busy doctors entering orders for tests don't tend to think about the supplies and people power needed to carry out those tests, Breeden notes. In the face of a shortage, or of strong evidence that a test is often over-ordered, an alert could help prioritize the tests for those who need them most.

Canadian experts have actually flagged PT/INR/PTT tests as a target for reducing unnecessary care, through the Choosing Wisely program. So has the American Society for Clinical Laboratory Science, a medical professional group.

In addition to Breeden, the study's authors are Steven J. Bernstein, MD, MPH, Rodney A. Hayward, MD, and A. Mark Fendrick.

Paper cited: "Evaluation of a Best Practice Advisory on Ordering Prothrombin Time, International Normalized Ratio, and Partial Thromboplastin Time Tests,"  JAMA Internal Medicine. DOI: 10.1001/jamainternmed.2022.2609


More Articles About:

Lab Notes Health Care Delivery, Policy and Economics All Research Topics Pharmacy Patient Safety Future Think Health Care Quality
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Small Pauses, Bigger Impact: Mindfulness in Action

What if well-being was built into the places where we live, learn and work? In this episode, Dr. Elizabeth Harry, is joined by three guests: recent past AMA president Dr. Bobby Mukkamala, who is board-certified in otolaryngology (head & neck surgery); Lauren Holaly-Zembo, CEO of the Crim Fitness Foundation; and Dr. Lisa Sancrant, Assistant Vice Chancellor for Health and Well-Being at UM-Flint, about how Flint, Michigan, is making mindfulness a community-wide priority. From classrooms to workplaces, they explore how small, accessible practices can support mental health, reduce stress, strengthen organizational cultures and help create healthier, more compassionate communities.
Mother sits on a couch with a laptop on her lap while an elementary school age boy sits next to her playing on a tablet device.
Health Lab

New questionnaire aims to improve understanding of demand avoidance in children, teens

Pathological demand avoidance is a pattern of intense distress and avoidance of demands in children. A new questionnaire from University of Michigan researchers creates a structured way to assess these behaviors.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.